Coating of adeno-associated virus with reactive polymers can ablate virus tropsim, enable retargeting and provide resistance to neutralising antisera

被引:52
作者
Carlisle, Robert C. [1 ]
Benjamin, Reuben [2 ]
Briggs, Simon S. [1 ]
Sumner-Jones, Stephanie [3 ]
McIntosh, Jenny [2 ]
Gill, Deborah [3 ]
Hyde, Steve [3 ]
Nathwani, Amit [2 ]
Subr, Vladimir [5 ]
Ulbrich, Karel [5 ]
Seymour, Leonard W. [1 ]
Fisher, Kerry D. [4 ]
机构
[1] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England
[2] UCL, Dept Haematol, London WC1E 6HX, England
[3] Univ Oxford, John Radcliffe Hosp, Clin Sci Lab, Nuffield Dept, Oxford OX3 9DU, England
[4] Hybrid Syst Ltd, Oxford Biobusiness Ctr, Oxford, England
[5] Acad Sci Czech Republic, Inst Macromol Chem, Prague 6, Czech Republic
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
AAV; HPMA; polymer coating; retargeting;
D O I
10.1002/jgm.1161
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Copolymers based on poly- [N-(2-hydroxypropyl) methacrylamide] (HPMA) have been used previously to enable targeted delivery of adenovirus. Here we demonstrate polymer-coating techniques can also be used to modify and retarget adeno-associated virus (AAV) types 5 and 8. Methods Three strategies for modifying transductional targeting of AAV were employed. The first involved direct reaction of AAV5 or AAV8 with amino-reactive HPMA copolymer. The second approach used carbodiimide (EDC) chemistry to increase the number of surface amino groups on the AAV5 capsid, thereby improving coating efficiency. in the third approach, the AAV5 genome was isolated from capsid proteins and delivered in a synthetic polyplex consisting of polyethylenimine (PEI) and HPMA. Results Efficient covalent attachment of HPMA copolymer to AAV5 could only be achieved following modification of the virus with EDC. Coating inhibited sialic acid dependent infection and provided a platform for retargeting via new ligands, including basic fibroblast growth factor. Retargeted infection was shown to be partially resistant to neutralising antisera. Delivery of AAV5 genomes using PEI and HPMA was efficient and provided absolute control of tropism and protection from antisera. In contrast AAV8 could be reacted directly with HPMA copolymer and allowed specific retargeting via the epidermal growth factor receptor, but gave no protection against neutralising antisera. Conclusions Reactive HPMA polymers can be used to ablate the natural tropism of both AAV8 and EDC-modified AAV5 and enable receptor-specific infection by incorporation of targeting ligands. These data show transductional targeting strategies can be used to improve the versatility of AAV vectors. Copyright (c) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:400 / 411
页数:12
相关论文
共 36 条
[1]   Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes [J].
Arnold, Gregory S. ;
Sasser, A. Kate ;
Stachler, Matthew D. ;
Bartlett, Jeffrey S. .
MOLECULAR THERAPY, 2006, 14 (01) :97-106
[2]   Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells [J].
Bettinger, T ;
Carlisle, RC ;
Read, ML ;
Ogris, M ;
Seymour, LW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (18) :3882-3891
[3]  
Büning H, 2003, CURR OPIN MOL THER, V5, P367
[4]   Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA [J].
Carlisle, R. C. ;
Briggs, S. S. ;
Hale, A. B. ;
Green, N. K. ;
Fisher, K. D. ;
Etrych, T. ;
Ulbrich, K. ;
Mautner, V. ;
Seymour, L. W. .
GENE THERAPY, 2006, 13 (22) :1579-1586
[5]   Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction [J].
Carlisle, RC ;
Etrych, T ;
Briggs, SS ;
Preece, JA ;
Ulbrich, K ;
Seymour, LW .
JOURNAL OF GENE MEDICINE, 2004, 6 (03) :337-344
[6]  
Cathomen T, 2004, CURR OPIN MOL THER, V6, P360
[7]   Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle [J].
Chirmule, N ;
Xiao, WD ;
Truneh, A ;
Schnell, MA ;
Hughes, JV ;
Zoltick, P ;
Wilson, JM .
JOURNAL OF VIROLOGY, 2000, 74 (05) :2420-2425
[8]   Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock [J].
Davidoff, AM ;
Ng, CYC ;
Sleep, S ;
Gray, J ;
Azam, S ;
Zhao, Y ;
McIntosh, JH ;
Karimipoor, M ;
Nathwani, AC .
JOURNAL OF VIROLOGICAL METHODS, 2004, 121 (02) :209-215
[9]   Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models [J].
Davidoff, AM ;
Gray, JT ;
Ng, CYC ;
Zhang, YB ;
Zhou, JF ;
Spence, Y ;
Bakar, Y ;
Nathwani, AC .
MOLECULAR THERAPY, 2005, 11 (06) :875-888
[10]   High levels of persistent expression of (A-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses [J].
De, BP ;
Heguy, A ;
Hackett, NR ;
Ferris, B ;
Leopold, PL ;
Lee, J ;
Pierre, L ;
Gao, GP ;
Wilson, JM ;
Crystal, RG .
MOLECULAR THERAPY, 2006, 13 (01) :67-76